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Pleuropulmonary blastoma is a dysontogenetic neoplasm of childhood, histologically characterized by
a primitive variably mixed blastematous and sarcomatous appearance. It presents a pattern of rapid
growth and is associated with a poor prognosis. We report the case of a 13-month-old girl, consulting for
wheezing, dyspnea and loss of appetite. Chest X-ray revealed a mediastinal deviation with a clear
appearance of the right lung. Computed tomography showed a voluminous emphysematous bulla of the
right lung and atelectasis of the lower lobe. The ﬁnal diagnosis was made on the basis of histological
features of a cystic tumour, showing blastematous elements associated with sarcomatous compound
conﬁrming the diagnosis of pleuropulmonary blastoma type I. Subsequent chemotherapy was per-
formed. Four years after the operation, the child is well with no evidence of disease recurrence or
metastasis.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
Pleuropulmonary blastoma (PPB) is an uncommon solid and/or
cystic intrathoracic childhood tumour, which belongs to the group
of dysontogenetic, neoplasms such as wilms’ tumour, hepato-
blastoma and neuroblastoma. It also affects adults and appears as
pulmonary and/or pleural-based mass, histologically characterized
by a primitive variably mixed blastematous and sarcomatous
appearance.1 It presents a pattern of rapid growth and is associated
with a poor prognosis.22. Case report
A 13-month-old girl was admitted to the paediatric surgical
department when she presented with a one-week history of
wheezing and dyspnea accompanied by loss of appetite. For 3 days,
she had vomiting, diarrhoea and fever. Physical examination
revealed a respiratory rate at 38/min with nasal ﬂare, intercostal
retraction and asymmetric chest. Pulmonary auscultation revealed
decreased breath sound in the right middle and lower chest,
without sibilant rale. Cardio-vascular examination was normal.
There was neither hepatosplenomegaly nor peripheral lymphade-
nopathy and no abnormal neurological symptoms. Chest X-ray: þ216 71 39 71 71.
n Brahim).
rved.revealed a mediastinal shift with a clear appearance of the 2/3 of
the right lung associated with a liquid level (Fig. 1). Computed
tomography showed what was considered as a voluminous
emphysematous bulla of the right lung and atelectasis of the lower
lobe associated with an abundant pleural effusion (Fig. 2). A
thoracotomy was then performed to relieve the patient, but it
revealed a voluminous tumour, measuring 15 cm in size, localized
in the upper lobe of the right lung. The latter was compressed and
repressed forward. After extraction of the tumour and resection of
the paracardiac lower lobe, examination of the thoracic cavity
showed no signiﬁcant adherence between the upper lobe and the
parietal pleura. There was no evidence of extension of this mass to
the chest wall or pericardium and no implants on the pleura. There
were no obviously enlarged mediastinal nodes. On macroscopic
examination, the tumour weighed 480 g and measured
1310 7 cm. At the cutting section, it was cystic and multi-
loculated, containing 1 L of clear serous ﬂuid. The walls of cysts
were thick, measuring 1–1.5 cm (Fig. 3). On microscopic examina-
tion, the cystic walls were lined with a high cylindrical epithelium,
often ciliated, standing on a stromawith a hypocellular appearance
associated with a cellular cambium layer, composed of round to
spindle shaped immature cells. Occasionally, some mesenchymal
cells had a rhabdomyoblastic differentiation (Fig. 4). A marked
vascular network was noted. No sarcomatous features were
depicted in different samples. Based on these features, the diag-
nosis of PPB type I was conﬁrmed. The child was then referred to an
oncologist who prescribed 6 courses of chemotherapy (IVA) with
Fig. 3. Macroscopic appearance: multi-loculated cystic tumour measuring
1310 7 cm.Fig. 1. Chest X-ray: mediastinal shift with a clear appearance of the 2/3 of the right
lung associated to a liquid level.
A. Chadli-Debbiche et al. / Respiratory Medicine CME 3 (2010) 120–122 121Holoxan, Actinomycin and Oncovin. At present, 4 years after
treatment, the child is well with no evidence of disease recurrence
or metastasis.3. Discussion
PPB is a rare primary malignant lung tumour, accounting for
0.25–0.5% of primary lung tumours.1 It was ﬁrst described by
Barnard in 1952 who named it embryoma of lung and was subse-
quently redeﬁned by both Spencer in 1961 and Manivel in 1988.
Since then, approximately 150 cases have been reported in the
literature.3,4 While 60% or more of cases occur in adults over 40
years, 20% occur in patients under 20 years and 75% of these are
under 10 years.3 An exceptional case of PPB has been diagnosed
prenatally, at 32 weeks of gestation.5 Most series report a female
predominance.6 Symptoms can be unspeciﬁc, such as dry cough,
fever, chest or abdominal pain and infections that persist despite
medical therapy. The uncommon symptoms are dyspnea andFig. 2. Computed tomography: giant emphysematous bulla of the right lung and
atelectasis of the lower lobe associated to an abundant pleural effusion.pneumothorax or respiratory distress. Our patient was a 13-month-
old girl, presenting with wheezing, dyspnea and loss of appetite. In
20% of the cases, the tumour is discovered fortuitously.7,8 In 38%,
children with PPB had radiologically identiﬁed pulmonary cysts,
prior to surgery. Inmore than one-third of these instances, the cysts
were supposed to be developmental or infectious and the children
were just watched over for several months often until a suspicious,
solid component had been developed. A computed tomography
scan examination conﬁrms the cystic lesion and shows possible
zones of necrosis, solid component or pleural involvement.9,10
Based on radiological features, several other diagnoses were sus-
pected like hydatid or bronchogenic cyst, pulmonary abscess, cystic
adenoma and congenital adenomatoid malformation. Imaging
study showed in the present case an emphysematous bulla, and the
diagnosis of PPBwas done by histological examination. This tumour
can be divided into 3 morphologic types, based on its cystic, cystic
and solid, or solid character, as determined by the gross and
microscopic ﬁndings The exclusively cystic or type I PPB is the least
complex and is presented at an earlier age than either type II or
type III PPB.1 The cystic lesion is usually located in the periphery ofFig. 4. Microscopic examination: the cystic walls were lined with a high cylindrical
epithelium, often ciliated, standing on a stroma with a cellular cambium layer,
composed of blastematous cells (Hematoxylin and eosin, 250) at the upper right:
mesenchymal cells with a rhabdomyoblastic differentiation (Hematoxylin and eosin,
400).
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the right lower lobe. It is believed that these three types are
a continuum: type I lesion progresses to type II and type III as the
cysts are replaced by a solid malignant tissue.9,10 In subsequent
recurrences the tumour becomes solid, anaplastic, multiphasic
with mesenchymal pattern. The gross features of type III PPB is
purely solid consisting of friable, gelatinous to mucoide, lobulated
tissue often accompanied by haemorrhage and necrosis.10 Histo-
logically, childhood PPB, unlike the adulthood one has embryonic-
like blastema and stroma, with the absence of a carcinomatous
component and potential for sarcomatous differentiation. Blas-
tematous foci are consistently seen and contain numerous mitotic
features and areas resembling rhabdomyosarcoma with large,
bizarre, pleomorphic, multinucleated mesenchymal cells present
over half of the cases. Immature and sarcomatous cartilage is
present in about 25% of the cases.3 In our case report, the tumour
was a PPB type I, diagnosed during histologic examination. Type I
lesions must be histologically differentiated from cystic adenama-
toid malformation and bronchogenic cyst. Type III must be differ-
entiated from the pulmonary tumours of childhood, such as
inﬂammatory myoﬁbroblastic tumour, Askin thoraco-abdominal
primitive neuroectodermal tumour, pulmonary metastasis and
pulmonary lymphoma.9 The histogenesis of PPB is still undeter-
mined. The co-expression of cytokeratin and vimentin in the
blastematous component provides some support to the concept
that a pluripotential blastematous cell may give rise to the
epithelial and mesenchymal elements of PPB. It has also been
suggested that PPB originates from residual embryonic tissue in the
lung, which through genetic and/or environmental inﬂuences,
generates pluripotential cells with different degrees of differenti-
ation. Various hypotheses have been formulated on the association
of PPB with pre-existing cystic disease of the lung including
congenital adenomatoid malformation, extralobar sequestration
and bronchogenic cysts. Priest reported that PPB and congenital
lung cysts may be associated in 38% of cases. Yet, the progression of
congenital adenomatoid malformation to PPB is to be proved and
these two entities are said to be curiously associated. However, PPB
has recently been identiﬁed in utero, indicating that these lesions
may be congenital in origin and thus malignant from the begin-
ning.7,11 Cytogenetic studies have repeatedly reported trisomy of
chromosome 8 or, more generally, gains of chromosome 8 in
addition to complex genetic abnormality. Furthermore, trisomy of
chromosome 2 has been reported by ﬂuorescence in situ hybrid-
ization (FISH).11 PPB is known to have a family association with
other neoplasms, but only two cases of PPB occurring in siblings
were reported in the literature.12 Autopsy case reports cited in the
literature document widespread visceral metastases in the central
nervous system, especially the brain, but also the orbit, and the iris.
Other common sites of metastases include bones, liver, soft tissues,
lymph nodes, pancreas, kidney and adrenals.8,13,14 The prognosis of
PPB is generally poor, with 5 year-survival of only 45% and 2 year-
survival of 62%.13,15 The prognosis is better for type I, which has
a survival rate of 83%, but only 42% for type II and III and this is even
after multimodality therapy. Primary treatment consists of radical
surgery. The surgical procedure of choice is lobectomy, as the
border between the lesion and normal parenchymamay be difﬁcult
to determine grossly, and usually the tumour spreads into lungparenchyma.7 Some authors suggest that postoperative chemo-
therapy should be strongly considered with type I to minimise the
possibility of recurrence. A combination of vincristine, actino-
mycin-D and cyclophosphamide has been used.10 Adjuvant therapy
has also been used for type II and III while radiotherapy is recom-
mended for tumours with known areas of residual disease.7,10
Adjuvant chemotherapy was given to our patient who is at present,
4 years later, well with no evidence of disease.4. Conclusion
Congenital cystic lesions should be followed up and never
underestimated because they may conceal a PPB. Diagnosis is
usually histologic and treatment should be submitted to a joint
analysis from a pulmonologist, an oncologist and a thoracic
surgeon. Early deﬁnitive surgery in PPB may have a positive impact
on survival. After resection, postoperative chemotherapy is strongly
recommended to prevent distant spread of the disease or transition
from PPB type I to PPB type III.
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